Skybiotech Healthcare share news, announcements and annual reports
BSE: 512036Textiles & ApparelsSmall Cap
SKYBIOTECH HEALTHCARE LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1985
Last close ₹116.00₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹116.00.
30 Oct: open ₹116.00, high ₹116.00, low ₹116.00
52-week range of traded prices to 30 Oct 2026
₹113.70Low, 29 Oct 2026₹218.20High, 2 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,866th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.91
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 14
Skybiotech Healthcare board meetings
125 filed, newest first. Page 1 of 3.
Aug 2026
11 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
May 2026
26 May · Board meeting
Meeting on 30 May 2026: audited results
Feb 2026
11 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Nov 2025
11 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Aug 2025
28 Aug · Board meeting
25 Aug · Board meeting
Meeting on 28 Aug 2025: increase in authorised capital11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
May 2025
27 May · Board meeting
Meeting on 30 May 2025: audited results
Feb 2025
12 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Nov 2024
14 Nov · Board meeting
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results7 Nov · Board meeting
Sep 2024
30 Sep · Board meeting
Meeting on 30 Sep 202430 Sep · Board meeting
Aug 2024
14 Aug · Board meeting
12 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
May 2024
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
29 Apr · Board meeting
Meeting on 29 Apr 20248 Apr · Board meeting
2 Apr · Board meeting
Meeting on 8 Apr 2024
Feb 2024
28 Feb · Board meeting
Meeting on 28 Feb 2024: preferential issue of shares8 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Dec 2023
28 Dec · Board meeting
21 Dec · Board meeting
Meeting on 28 Dec 2023: preferential issue of shares
Nov 2023
14 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results